Pfizer Announces 2025 Grant Recipients Driving Innovative Solutions in Cancer Care

Pfizer announced the recipients of a series of grants to help advance oncology research. An investment of $900,000 has been made across different projects to support the development of patient-centric solutions for some of Canada’s most diagnosed cancers: lung, colorectal, prostate, and bladder cancer.